Research from other tumor types suggests that EMT progression is mediated by immune regulation; specifically, cytokines such as TGF-beta, IL-10, and immune cell populations such as tumor-associated macrophages and some subsets of CD4+ and CD8+ T cells appear to be critical to this regulation [108,109,110,111,112]. This evidence concerns the gene IL10 and neoplasm.